Physician profile
Ronald Higgins
NPI 1457355331
$1,846.48
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,584 · 2020: $234 · 2021: $11.23 · 2022: $17.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.40 | 2019-2021 | |
| Janssen Biotech, INC. | $319.07 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $167.63 | 2019-2020 | |
| Galderma Laboratories, L.P. | $155.84 | 2019-2020 | |
| Lilly USA, LLC | $118.42 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $115.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $81.09 | 2019-2020 | |
| Celgene Corporation | $68.96 | 2019 | |
| Epi Health, LLC | $63.52 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $50.98 | 2019-2020 | |
| Almirall LLC | $46.39 | 2019 | |
| Genentech USA, INC. | $42.52 | 2019 | |
| Ucb, INC. | $33.59 | 2019 | |
| Leo Pharma INC. | $21.61 | 2020 | |
| Amgen INC. | $20.04 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $18.28 | 2019 | |
| Allergan, INC. | $17.57 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $17.36 | 2019 | |
| Aclaris Therapeutics, INC. | $15.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.24 | 2020 | |
| Prugen, INC. Pharmaceuticals | $12.68 | 2019 | |
| Smith+Nephew, INC. | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.